Teva Slips FCA Suit, Giving DOJ Another Granston Memo Win
Law360 (November 27, 2019, 4:09 PM EST) -- A Pennsylvania federal judge has torpedoed a whistleblower company’s False Claims Act case against Teva Pharmaceuticals at the request of the U.S. Department of Justice, further solidifying the government’s mostly successful campaign to end disfavored FCA suits.
U.S. District Judge Jan E. DuBois on Nov. 25 granted the DOJ's motion to dismiss a case filed by the National Healthcare Analysis Group, a company that specializes in bringing FCA suits. The suit alleged that Teva Pharmaceuticals USA Inc. encouraged doctors to write prescriptions for multiple sclerosis drug Copaxone in exchange for kickbacks in the form of free nursing services and assistance obtaining...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!